Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers
Home › VA › FAIRFAX › TRUSTED DOCTORS LLC

TRUSTED DOCTORS LLC

NPI: 1083793525 · FAIRFAX, VA 22033 · Pediatrics Physician · NPI assigned 11/03/2006

$13.54M
Total Medicaid Paid
427,743
Total Claims
384,406
Beneficiaries
92
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialTERRY, SHERRYL (ADMINISTRATOR)
NPI Enumeration Date11/03/2006

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 25,906 $1.02M
2019 39,026 $980K
2020 38,690 $1.05M
2021 62,082 $2.00M
2022 58,553 $2.47M
2023 99,919 $3.30M
2024 103,567 $2.71M

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 59,768 54,238 $5.35M
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 61,416 55,975 $4.16M
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) 8,817 8,160 $717K
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) 7,533 6,390 $568K
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) 6,466 6,168 $533K
90686 18,191 16,140 $268K
0240U 2,110 2,072 $255K
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) 2,394 2,235 $215K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) 4,266 4,131 $145K
96160 47,645 44,853 $129K
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) 10,762 9,923 $127K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 9,710 8,569 $116K
96127 20,731 16,941 $103K
87811 Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) 2,625 2,447 $96K
90670 3,657 2,953 $84K
90460 Immunization administration through 18 years of age via any route, first or only component 38,993 32,611 $79K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 4,285 2,427 $66K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 9,207 8,262 $40K
96110 Developmental screening, with scoring and documentation, per standardized instrument 3,914 3,328 $33K
90698 1,756 1,448 $29K
90461 10,844 9,087 $28K
90656 1,658 1,626 $28K
90651 556 543 $28K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 794 778 $27K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel 176 172 $22K
99460 226 221 $20K
99238 Hospital discharge day management, 30 minutes or less 290 283 $20K
90619 183 180 $18K
90680 1,114 921 $18K
99173 6,719 6,390 $16K
90677 144 138 $15K
99215 Prolong outpt/office vis 119 111 $15K
0002A 415 396 $15K
0001A 444 429 $15K
99000 12,567 10,663 $12K
99177 2,639 2,491 $11K
96161 3,017 2,558 $7K
0071A 179 179 $7K
90633 497 459 $7K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B 55 53 $7K
99051 1,490 1,229 $6K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 832 802 $6K
90697 154 152 $6K
0072A 127 127 $5K
90685 454 429 $5K
90744 379 350 $5K
87807 351 329 $5K
92551 432 426 $4K
88738 1,025 952 $4K
90688 331 320 $4K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 90 83 $3K
90472 Immunization administration, each additional vaccine (list separately) 715 653 $3K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 64 57 $3K
90734 117 106 $3K
85018 1,187 1,126 $3K
97803 168 137 $2K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity 219 197 $2K
92567 151 148 $2K
87428 80 73 $2K
99050 137 116 $2K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 135 101 $2K
90648 77 67 $1K
90480 45 45 $1K
90715 53 52 $970.24
92587 90 85 $932.76
0081A 25 22 $906.13
99188 51 46 $881.05
90621 12 12 $593.55
99072 4,824 4,207 $555.01
90723 28 25 $535.44
0082A 22 12 $490.71
92558 1,646 1,564 $438.05
94760 372 308 $417.11
90674 16 16 $373.04
36416 4,282 3,813 $231.65
G9920 Screening performed and negative 28,206 26,954 $225.68
90700 12 12 $155.20
90710 13 13 $144.10
90696 12 12 $133.10
A7003 Administration set, with small volume nonfiltered pneumatic nebulizer, disposable 98 76 $108.18
83655 13 12 $93.81
87070 19 18 $67.68
87081 24 13 $50.80
G0447 Face-to-face behavioral counseling for obesity, 15 minutes 5,520 5,498 $42.77
36415 Collection of venous blood by venipuncture 14 14 $23.10
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg 41 39 $2.70
G0444 Annual depression screening, 5 to 15 minutes 444 444 $1.67
H0049 Alcohol and/or drug screening 764 762 $0.01
G9919 Screening performed and positive and provision of recommendations 1,276 1,210 $0.00
G8431 Screening for depression is documented as being positive and a follow-up plan is documented 30 28 $0.00
3008F 3,638 3,625 $0.00
G8510 Screening for depression is documented as negative, a follow-up plan is not required 556 540 $0.00